中文版
  • Company news


Investee Company: FlashEx Secures USD 125 Million in Series D2 Round

Mar 30, 2021

On March 30, FlashEx, a provider of short-distance and same-city logistics services, said on Tuesday that it has raked in $125 million in a Series D2 round fund...

Investee Company:Zhihu Lists on New York Stock Exchange

Mar 26, 2021

Oceanpine Capital Investee company——Zhihu (NYSE: ZH) on March 26th EST listed on the New York Stock Exchange. The issue price is US$9.5/ADS...

Dave Chenn visited BOE Technology Group to conduct strategic cooperation and exchanges around industrial resources

Mar 12, 2021

On March 11, 2021, Mr. Dave Chenn, CEO and Managing Partner of Oceanpine Capital, led the company's executives to visit BOE Technology, had a cordial talk with Xiaodong Liu ,Chairman of BOE and other group executives...

Investee Company:Julive has raised $62 million in a Series C+ round

Mar 11, 2021

Chinese O2O real estate agency Julive announced on Thursday the completion of a Series C+ funding round at $62 million led by Tencent and growth equity investment firm Oceanpine Capital...

Investee Company:Chinese GPU startup Moore Threads raises billions of yuan to take on Nvidia

Feb 25, 2021

Semiconductor company Moore Threads founded just 100 days ago, has closed two rounds of funding amounting to “several” RMB 1 billion (USD 155 million)...

Investee Company:Teon Therapeutics Completes $30 Million Series A Financing

Feb 25, 2021

SAN FRANCISCO, Feb. 23, 2021 /PRNewswire/—Teon Therapeutics, a biopharmaceutical company developing small molecules that inhibit the immunosuppressive and cancer-promoting signaling pathways, today announced the completion of a $30M Series A financing...

Investee Company:Yisheng Biopharma moves COVID-19 vaccine to clinic after $130M series B

Feb 24, 2021

China’s Yisheng Biopharma Ltd has closed its $130-million Series B round co-led by returning investor OrbiMed and deep tech-focused investor Oceanpine Capital...

Investee Company:Clover Biopharmaceuticals Raises $230 Million in Oversubscribed Series C Financing

Feb 23, 2021

CHENGDU, CHINA – 23 February 2021 – Clover Biopharmaceuticals, a global clinical-stage biotechnology company developing transformative biologics as vaccines and therapeutics for the world’s most debilitating diseases, today announced the completion of an

Investee Company:TigerGraph Raises $105 Million to Accelerate Graph Analytics on the Cloud

Feb 17, 2021

Feb. 17, 2021 – TigerGraph provider of the leading graph analytics platform, today announced it has raised $105 million in Series C funding, the largest funding round to date within the graph database and analytics market...

Investee Company:YanRong Tech Completed RMB 120 Million Series A+ Financing

Feb 03, 2021

China's next-generation cloud storage solutions developer YanRong Tech has closed a 120 million yuan ($19 million) funding in its Series A+ round...
2345678